PCRX
$62.13
Pacira Pharm
$.15
.24%
PCRX
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  $0.46
Revenue:  $127.31 Mil
Tuesday
Aug 3
8:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when PCRX reports earnings?
Beat
Meet
Miss

Where is PCRX's stock price going from here?
Up
Flat
Down
Stock chart of PCRX
Analysts
Summary of analysts' recommendations for PCRX
Score
Grade
Pivots
Resistance
$65.81
$64.25
$63.12

$61.56

Support
$60.42
$58.86
$57.73
Tweet
Growth
Description
Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development, commercialization and manufacture of new pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. Pacira Pharmaceuticals, Inc. is based in New Jersey.
Peers
InterCeptVertex PharmaceuticalsBioMarin PharmaceuticalRegeneron PharmaceuticalsUltragenyx PharmaceuticalBristol-Myers SquibbPfizerZoetisEli LillyMerck & Co.